Arbutus Biopharma Corporation P/B Ratio 2011-2026 | ABUS

Annual P/B Ratio Arbutus Biopharma Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
11.1	8.43	4.2	3.08	2.44	2.95	2.19	1.02	1.53	0.666	0.261	6.53	3.36	1.62	4.67

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.1	0.261	3.6

P/B Ratio of other stocks in the Biotechnology industry

Issuer	P/B Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.28	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	1.23	$ 8.59	7.44 %	$ 84.9 M	USA
Alterity Therapeutics Limited ATHE	125	$ 3.66	-1.48 %	$ 8.81 B	Australia
I-Mab IMAB	1.12	-	-	$ 866 M	China
AlloVir ALVR	-0.258	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	0.364	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.88	-	-	$ 40.3 B	USA
Genfit SA GNFT	596	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	15.7	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	-31.5	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.13	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	7.56	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	1.58	$ 21.43	5.2 %	$ 1 B	USA
Acorda Therapeutics ACOR	0.154	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	6.81	-	-	-	Russia
Adverum Biotechnologies ADVM	1.08	-	-	$ 86.2 M	USA
Advaxis ADXS	0.113	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	0.781	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	0.00262	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	1.4	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	10.3	$ 1.47	4.64 %	$ 378 M	USA
Applied Genetic Technologies Corporation AGTC	0.382	-	-	$ 26.5 M	USA
Allakos ALLK	0.674	-	-	$ 28.6 M	USA
Aptinyx APTX	0.248	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	32	$ 3.05	4.28 %	$ 5.02 M	Israel
Aquestive Therapeutics AQST	-13.9	$ 4.2	2.94 %	$ 449 M	USA
Aravive ARAV	5.67	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	18.2	$ 24.1	-0.45 %	$ 3.07 B	USA
AIkido Pharma AIKI	0.492	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	3.87	$ 32.61	1.15 %	$ 2.17 B	USA
Autolus Therapeutics plc AUTL	1.81	$ 1.47	-1.34 %	$ 391 M	Britain
Aptose Biosciences APTO	-0.511	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	0.908	-	-	$ 1.41 B	USA
AVROBIO AVRO	0.594	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	0.994	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	2.07	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	4.34	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	5.13	-	-	$ 867 M	Germany
Brainstorm Cell Therapeutics BCLI	-0.815	-	-2.5 %	$ 5.88 M	USA
BeiGene, Ltd. BGNE	75.9	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	0.736	-	0.23 %	$ 488 M	USA
Akari Therapeutics, Plc AKTX	285	$ 4.1	4.59 %	$ 276 B	Britain
Allena Pharmaceuticals ALNA	3.16	-	3.16 %	$ 1.9 M	USA
Esperion Therapeutics ESPR	-1.86	$ 2.23	2.53 %	$ 464 M	USA
Evogene Ltd. EVGN	0.869	$ 0.79	-2.54 %	$ 27.9 M	Israel
Baudax Bio BXRX	-0.0321	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	2.53	$ 3.23	3.19 %	$ 325 M	USA
Alpine Immune Sciences ALPN	1.5	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	11.7	-	-	$ 3.45 B	USA
Aileron Therapeutics ALRN	0.702	-	10.36 %	$ 9.8 M	USA